Sage Therapeutics(SAGE) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist

8.600
+0.070+0.82%

Close Mar 26 16:00 ET

8.620
+0.020+0.23%

Post 16:53 ET

528.74MMarket Cap-1.31P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
BenzingaMar 25 06:46 ET
Sage Active Expands AI Capabilities to Help European Small Businesses Grow Faster
SAGE Sage TherapeuticsMar 25 00:00 ET
The Sage Small Business Tracker Q4 2024
SAGE Sage TherapeuticsMar 13 00:00 ET
BofA Securities Maintains Sage Therapeutics(SAGE.US) With Sell Rating, Raises Target Price to $5
Moomoo NewsMar 11 13:31 ET · Ratings
Sage Moved to Underperform at BofA; Says Biogen's Buyout Impact Has Passed
Seeking AlphaMar 11 12:02 ET
Sage Therapeutics Resumed With an Underperform at BofA
TipRanksMar 10 17:10 ET

Comments

Stock_Drift

Jan 13 07:27

$Sage Therapeutics (SAGE.US)$

Jaguar8

Jan 13 06:02

🟢 Watchlist JANUARY 13, 2025, Monday. NFA. Those with 🟢 are my top picks

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...

Jaguar8

Jan 11 07:49

ADDED NEWS

$Sage Therapeutics (SAGE.US)$
Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen
Friday, 10th January at 6:49 pm
No Shareholder Action Required at This Time
Sage Therapeutics, Inc. (NASDAQ: SAGE) ("The Company"), today confirmed that Biogen Inc. (NASDAQ: BIIB) ("Biogen") has submitted to the Company an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen for $7.22 per share...

Jaguar8

Jan 11 06:43

NEWS

$Sage Therapeutics (SAGE.US)$
Biogen Inc - Submits Non-Binding Proposal to Buy All Outstanding Shares of Sage Therapeutics' Common Stock Not Owned by Biogen for $7.22/Share in Cash

Market Insights

Symbol Mini Chart % Chg

Petroleo Brasileiro SA Petrobras

Unlock the Full List